Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
132M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
21.1M
-
Shares change
-
+649K
-
Total reported value, excl. options
-
$468M
-
Value change
-
+$14.6M
-
Put/Call ratio
-
0.23
-
Number of buys
-
25
-
Number of sells
-
-33
-
Price
-
$22.20
Significant Holders of RAPT Therapeutics, Inc. - Common Stock (RAPT) as of Q1 2021
97 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock as of Q1 2021.
RAPT Therapeutics, Inc. - Common Stock (RAPT) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.1M shares
of 132M outstanding shares and own 15.98% of the company stock.
Largest 10 shareholders include The Column Group LLC (3.89M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.58M shares), PERCEPTIVE ADVISORS LLC (2.48M shares), KPCB XV Associates, LLC (1.95M shares), Ponoi Management, LLC (1.6M shares), BlackRock Inc. (1.39M shares), WELLINGTON MANAGEMENT GROUP LLP (1M shares), REGENTS OF THE UNIVERSITY OF CALIFORNIA (1M shares), Alphabet Inc. (831K shares), and VANGUARD GROUP INC (751K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.